IN2014DN09948A - - Google Patents

Info

Publication number
IN2014DN09948A
IN2014DN09948A IN9948DEN2014A IN2014DN09948A IN 2014DN09948 A IN2014DN09948 A IN 2014DN09948A IN 9948DEN2014 A IN9948DEN2014 A IN 9948DEN2014A IN 2014DN09948 A IN2014DN09948 A IN 2014DN09948A
Authority
IN
India
Application number
Inventor
Peter Gagnon
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of IN2014DN09948A publication Critical patent/IN2014DN09948A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
IN9948DEN2014 2012-05-31 2014-11-24 IN2014DN09948A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653752P 2012-05-31 2012-05-31
PCT/SG2013/000049 WO2013180650A1 (en) 2012-05-31 2013-02-06 Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives

Publications (1)

Publication Number Publication Date
IN2014DN09948A true IN2014DN09948A (en) 2015-08-14

Family

ID=49673721

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9948DEN2014 IN2014DN09948A (en) 2012-05-31 2014-11-24

Country Status (8)

Country Link
US (1) US10246506B2 (en)
EP (1) EP2855502B1 (en)
JP (2) JP2015519361A (en)
KR (1) KR102067445B1 (en)
CN (1) CN104507953B (en)
IN (1) IN2014DN09948A (en)
SG (2) SG11201407812SA (en)
WO (1) WO2013180650A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150115745A (en) * 2013-02-06 2015-10-14 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Methods for reducing aggregate content in protein preparations
EP2961759A4 (en) * 2013-02-26 2016-09-28 Agency Science Tech & Res Protein purification in the presence of nonionic organic polymers and electropositive surfaces
US10253063B2 (en) 2013-02-28 2019-04-09 Agency For Science, Technology And Research Protein purification in the presence of nonionic organic polymers at elevated conductivity
CN106061993A (en) * 2014-02-27 2016-10-26 新加坡科技研究局 Methods for reducing aggregate content of protein preparations by treatment with aryl anions
SG11201607098SA (en) * 2014-02-27 2016-09-29 Agency Science Tech & Res Antibody purification process
US20160074515A1 (en) 2014-06-20 2016-03-17 Reform Biologics, Llc Viscosity-reducing excipient compounds for protein formulations
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
SG11201809685XA (en) * 2016-06-15 2018-11-29 Agency Science Tech & Res A method of enhancing the performance of chromatography methods for purification of proteins
EP3484520A4 (en) 2016-07-13 2020-07-29 Reform Biologics, LLC Stabilizing excipients for therapeutic protein formulations
DE102016010601B4 (en) 2016-09-01 2018-11-08 Sartorius Stedim Biotech Gmbh A process for the purification of viruses or virus-like particles using a crosslinked cellulose hydrate membrane
WO2019036619A1 (en) * 2017-08-18 2019-02-21 Reform Biologics, Llc Stabilizing excipients for therapeutic protein formulations
CN113493570B (en) * 2020-04-01 2022-11-01 中国科学院理化技术研究所 Method for reducing endotoxin in gelatin by adopting allantoin

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
CZ290029B6 (en) * 1993-10-06 2002-05-15 Amgen Inc. Phospholipid-protein preparation
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
SE9500778D0 (en) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE0201257D0 (en) * 2002-04-25 2002-04-25 Medical Invest In Sweden Ab Improved Separation
CN1286453C (en) * 2003-07-25 2006-11-29 复旦大学 Method for stablizing protein medicine and its application in microball preparation
EP2120915B1 (en) 2007-01-22 2011-09-28 Genentech, Inc. Polyelectrolyte precipitation and purification of antibodies
JP5496898B2 (en) * 2007-10-12 2014-05-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Methods and agents for protein refolding
AU2009256308A1 (en) 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
EP2241886A1 (en) * 2009-04-15 2010-10-20 Beckman Coulter Biomedical Limited Homogeneous agglutination immunoassay method and kit for such method
WO2012040216A1 (en) * 2010-09-20 2012-03-29 Bio-Rad Laboratories, Inc. Dissociation of product-complexed contaminants in chromatography
SG11201407801VA (en) * 2012-05-31 2014-12-30 Agency Science Tech & Res Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
EP2855504B1 (en) * 2012-05-31 2018-10-24 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
KR20150023297A (en) * 2012-05-31 2015-03-05 에이전시 포 사이언스, 테크놀로지 앤드 리서치 Selective binding of biological targets to solid phase ureides

Also Published As

Publication number Publication date
SG11201407812SA (en) 2014-12-30
US10246506B2 (en) 2019-04-02
US20150148526A1 (en) 2015-05-28
CN104507953B (en) 2018-05-18
EP2855502A4 (en) 2016-02-17
WO2013180650A1 (en) 2013-12-05
EP2855502A1 (en) 2015-04-08
SG10201606990TA (en) 2016-10-28
KR102067445B1 (en) 2020-01-17
EP2855502B1 (en) 2019-06-26
CN104507953A (en) 2015-04-08
KR20150028231A (en) 2015-03-13
JP2017222699A (en) 2017-12-21
JP6491277B2 (en) 2019-03-27
JP2015519361A (en) 2015-07-09

Similar Documents

Publication Publication Date Title
BR112015010070A2 (en)
BR112014017635A2 (en)
BR112014017614A2 (en)
BR112014019182A2 (en)
BR112014017625A2 (en)
BR112014017659A2 (en)
BR112014017646A2 (en)
BR112014017638A2 (en)
BR112014019038A2 (en)
BR112014018007A2 (en)
BR112014017607A2 (en)
BR112013027865A2 (en)
BR112014018943A2 (en)
BR112014017634A2 (en)
BR112014017609A2 (en)
BR112014017644A2 (en)
BR112014017647A2 (en)
BR112014017618A2 (en)
IN2014DN09948A (en)
BR112014017630A2 (en)
BR112014017652A2 (en)
BR112014017621A2 (en)
BR112014017622A2 (en)
BR112014017627A2 (en)
BR112014017623A2 (en)